Literature DB >> 9091329

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.

E J van Santbrink1, W C Hop, B C Fauser.   

Abstract

OBJECTIVE: To investigate the predictive value of polycystic ovaries for endocrine signs of polycystic ovary syndrome (PCOS).
DESIGN: Controlled descriptive study.
SETTING: Academic tertiary care fertility clinic. PATIENT(S): Normogonadotropic (FSH levels between 1 and 10 mIU/mL conversion factor to SI unit, 1.0) oligomenorrheic or amenorrheic women visiting our fertility clinic and a control group of regularly cycling, healthy, normal weight volunteers recruited by advertisement. INTERVENTION(S): Single blood samples and transvaginal sonography were performed. MAIN OUTCOME MEASURE(S): Serum levels of FSH, LH, androstenedione (A), and T and ovarian volume, ovarian stroma density, and follicle number. RESULT(S): In control women, the 95th percentile was calculated for ovarian volume, follicle number, and stroma count as well as endocrine parameters. The use of these upper limits of normal in the study group resulted in 217 (66%) patients with polycystic ovaries on ultrasound (defined as increased mean ovarian volume and/or mean follicle number per ovary), whereas only 120 (36%) patients exhibited elevated serum androgens (increased A and/or T concentrations) and 155 (47%) showed elevated LH levels. Sensitivity and specificity of single or combined sonographic parameters for prediction of elevated serum LH or androgen concentrations were limited. CONCLUSION(S): In the study group of normogonadotropic oligomenorrhea or amenorrheic infertile women, we set strict cutoff levels for various criteria used in the literature for defining PCOS. Groups defined by sonographic or endocrine PCOS criteria did overlap, but sonographic parameters had limited predictive value for abnormal hormone serum levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9091329     DOI: 10.1016/s0015-0282(97)80068-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Retrieval, maturation, and fertilization of immature oocytes obtained from unstimulated patients with polycystic ovary syndrome.

Authors:  N G Beckers; M H Pieters; L Ramos; G H Zeilmaker; B C Fauser; D D Braat
Journal:  J Assist Reprod Genet       Date:  1999-02       Impact factor: 3.412

Review 2.  ACP best practice no 170. Investigation of infertility with the emphasis on laboratory testing and with reference to radiological imaging.

Authors:  C Williams; T Giannopoulos; E A Sherriff
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

3.  Polycystic ovary syndrome and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Fertil Steril       Date:  2007-01-22       Impact factor: 7.329

4.  Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update.

Authors:  Subeka Abraham Gnanadass; Yogamaya Divakar Prabhu; Abilash Valsala Gopalakrishnan
Journal:  Arch Gynecol Obstet       Date:  2021-01-13       Impact factor: 2.344

5.  Conventional IVF versus ICSI in sibling oocytes from couples with endometriosis and normozoospermic semen.

Authors:  Alisa Komsky-Elbaz; Arieh Raziel; Shevach Friedler; Deborah Strassburger; Esti Kasterstein; Daphna Komarovsky; Raphael Ron-El; Ido Ben-Ami
Journal:  J Assist Reprod Genet       Date:  2012-12-28       Impact factor: 3.412

6.  Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls.

Authors:  Michele Brown; Alice S Park; Rana F Shayya; Tanya Wolfson; H Irene Su; R Jeffrey Chang
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

Review 7.  Diagnostic criteria for polycystic ovarian syndrome.

Authors:  F J Broekmans; B C J M Fauser
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

8.  Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial.

Authors:  Neriman Bayram; Madelon van Wely; Eugenie M Kaaijk; Patrick M M Bossuyt; Fulco van der Veen
Journal:  BMJ       Date:  2004-01-24

9.  LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.

Authors:  F P Hohmann; J S E Laven; A G M G J Mulders; J J L Oberyé; B M J L Mannaerts; F H de Jong; B C J M Fauser
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

10.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.